Will My Daughter Be a Triple-Positive Breast Cancer Pioneer?

May 25th 2022

By Debbie Legault

I haven’t seen many 10-year triple-positive breast cancer survivors in my online support groups, but I can’t help but wonder: will my daughter be the one?

Trial Will Investigate Drug Duo in Solid Cancers With MAPK Pathway Aberrations

May 25th 2022

By Brielle Benyon

Patients can still talk to their clinicians about enrolling in a sub-study of the FIRELIGHT-1 trial, analyzing tovorafenib plus pimasertib in progressive or refractory solid tumors with MAPK pathway aberrations.

Clinical Trial to Assess Experimental Drug as Single-Agent, and Combined With Keytruda Across Several Solid Tumors Launches

May 25th 2022

By Ryan McDonald

The aim of the early-stage trial is to identify the safety of the experimental drug as either a single-agent therapy as well as in combination with Keytruda in adults with multiple solid tumors.

I Was Blindsided by a Cancer I’ve Never Heard Of

May 24th 2022

I was told that I would miscarry my pregnancy, but continued to feel more pregnant, leading to my molar pregnancy diagnosis — a condition I’ve never heard of before. 

The Integration of Complementary Cancer Care May ‘Accelerate’ in Coming Years, Says Patrick Dempsey

May 24th 2022

By Brielle Benyon

Actor and cancer advocate Patrick Dempsey predicts that more focus will be put on complementary cancer care, such as nutrition and environmental factors, over the next several years.